U.S. market Closed. Opens in 1 day 7 hours 52 minutes

CAPR | Capricor Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue25.18M2.55M244.90K310.25K1.01M1.67M1.37M3.19M3.78M4.79M503.23K195.50K1.35MN/AN/AN/A101.40KN/AN/AN/A2.18K11.48KN/AN/AN/A
Cost of Revenue1.07M694.87K245.70K8.46M5.14M12.07M10.77M16.04M13.76M7.79M5.20M2.63MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit24.11M1.85M-799.00-8.15M-4.14M-10.40M-9.40M-12.85M-9.98M-3.00M-4.69M-2.44M1.35MN/AN/AN/A101.40KN/AN/AN/A2.18K11.48KN/AN/AN/A
Operating Expenses48.19M32.25M21.18M14.00M8.74M17.00M14.23M20.17M16.39M10.80M7.41M2.64M6.25M6.29M7.88M13.40M9.60M60.40K18.86K18.98K18.34K29.26K22.30K36.52K200.00
Selling, General & Admin12.37M10.43M7.61M5.54M3.60M4.93M4.76M4.93M4.37M3.02M2.21M1.61M2.12M2.21M3.42M3.92M4.48M60.40K18.86K18.98K18.34K29.26K22.22K10.43KN/A
Research & Development36.45M21.82M13.57M8.46M5.14M12.07M10.77M16.04M13.76M7.79M5.20M1.02M4.14M4.08M4.47M9.48M5.12MN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A190.58K548.21KN/AN/AN/AN/AN/AN/AN/AN/A545.88KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A83.0026.09K200.00
Operating Income-24.08M-29.70M-20.94M-13.69M-7.73M-15.33M-12.86M-16.98M-12.61M-6.02M-6.90M-2.44M-4.90M-6.29M-7.88M-13.40M-9.50M-60.40K-18.86K-18.98K-16.16K-17.78K-22.30K-36.52K-200.00
Other Expenses / Income1.79M677.85K915.92K32.94K92.07K135.99K15.29M-1.83M-245.51K-198.61K-1.99M207.00K14.39K262.06K11.41K268.39K-802.34K-950.00N/A900.0016.16K2.19KN/AN/AN/A
Before Tax Income-22.29M-29.02M-20.02M-13.66M-7.64M-15.19M2.43M-18.81M-12.86M-6.22M-8.89M-1.89M-4.88B-6.03B-7.87B-13.13B-10.30M-61.35KN/A-18.08KN/A-15.59KN/AN/AN/A
Income Tax ExpensesN/A-677.00-613.41K-176.83K-264.03K135.99K254.63K218.95K137.76K200.50K58.13KN/A-14.39K-262.06K-11.41K-268.39K1.09MN/A18.86KN/A16.16KN/AN/AN/A200.00
Net Income-22.29M-29.02M-19.41M-13.48M-7.38M-15.19M2.43M-18.81M-12.86M-6.22M-8.89M-1.89M-4.88M-6.03M-7.87M-13.13M-10.30M-61.35K-18.86K-18.08K-16.16K-15.59K-22.30K-36.52K-200.00
Interest ExpensesN/AN/AN/AN/AN/AN/A398.81K344.67K248.63K200.50K58.13KN/AN/AN/AN/A137.001.09M950.00N/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding26.78M24.55M23.09M15.57M3.71M2.94M2.32M1.86M1.59M1.17M1.05M994.52K74.66K64.34K50.93K48.25K33.88K27.59K1.51K1.51K1.51K1.51K1.51K1.38K1.00K
Diluted Shares Outstanding26.78M24.55M23.09M15.57M3.71M2.94M2.68M1.86M1.59M1.17M1.05M994.52K74.66K64.34K50.93K48.25K33.88K27.59K1.51K1.51K1.51K1.51K1.51K1.38K1.00K
EBITDA-23.01M-29.16M-20.69M-13.55M-7.56M-15.17M-12.72M-18.33M-12.50M-5.97M-6.88M-1.89M-4.88M-6.02M-7.71M-13.02M-9.50M-2.50M-18.86K-19.88K-16.16K-19.97K-22.22K-36.32K200.00
EBITDA Margin-91.39%-1,144.18%-8,449.54%-4,366.18%-752.41%-907.61%-930.25%-574.51%-330.98%-124.81%-1,366.36%-965.11%-360.08%0.00%0.00%0.00%-9,369.29%0.00%0.00%0.00%-739.79%-173.90%0.00%0.00%0.00%
EBIT-22.29M-29.02M-20.02M-13.66M-7.64M-15.06M3.08M-18.24M-12.47M-5.82M-8.78M-1.89M-4.90M-6.29M-7.88M-13.40M-8.12M-60.40KN/A-18.08KN/A-15.59K-22.30K-36.52KN/A
EBIT Margin-88.52%-1,138.50%-8,175.86%-4,401.94%-760.36%-900.77%225.64%-571.87%-330.27%-121.49%-1,743.86%-968.31%-361.70%0.00%0.00%0.00%-8,010.36%0.00%0.00%0.00%0.00%-135.73%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙